FDA removes positive test requirement for two COVID-19 outpatient therapies
The Food and Drug Administration last week removed the requirement for a positive COVID-19 test result to prescribe Paxlovid to certain adult and pediatric patients and Lagevrio to certain adults at risk of progressing to severe COVID-19. The agency continues to recommend that health care providers use direct SARS-CoV-2 viral testing to help diagnose COVID-19, but said it recognizes that providers may in rare instances diagnose COVID-19 in patients with a negative test result but symptoms and a recent known exposure to COVID-19. For more information, see the updated Paxlovid and Lagevrio fact sheets for health care providers.
Related News Articles
Headline
The Pfizer and Moderna COVID-19 vaccines can cause myocarditis, but do not appear to cause infertility, Guillain-Barré syndrome, Bell’s palsy, thrombosis with…
Headline
Centers for Disease Control and Prevention Director Mandy Cohen, M.D., Feb. 28 endorsed a recommendation by its Advisory Committee on Immunization Practices…
Headline
A CDC study released Dec. 21 found low COVID-19 and flu vaccination coverage for most adults, and low RSV vaccination coverage for adults aged 60 and…
Headline
Fewer than one in four health care professionals working in acute care hospitals and nursing homes were up to date with COVID-19 vaccination during the 2022-23…
Headline
Children under age 12 should receive a 0.25 milliliter dose of the 2023-24 Moderna COVID-19 vaccine, not the full vial for that age group, the Food and Drug…
Headline
The Department of Health and Human Services Oct. 27 urged Merck and Pfizer to work with private insurers to maintain access to their COVID-19 oral antiviral…